CMS Hospital Price Transparency Rule To Begin Public Reveal Of Device-Related Procedure Prices, Test Costs In 2021

The US Medicare agency on 15 November released a final cost transparency rule calling on hospitals to detail their standard “shoppable services” charges for X-rays, advanced imaging, laboratory tests and an array of other device-related procedures, beginning on 1 January 2021. Meanwhile, an accompanying proposed rule released by the CMS on the same day would require insurance health plans to provide to participants and beneficiaries the insurers’ negotiated rates for all covered health-care items and services.

calculator and stationery items on the table - Image

The US Centers for Medicare and Medicaid Services (CMS) released a rule on 15 November finalizing hospital price transparency policies to make all items and services at every US hospital more transparent to patients, so they can know in advance what they might pay for health-care services.

On the same day, the CMS posted a proposed “Transparency in Coverage” rule to require most employer-based group health plans...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Policy & Regulation

More from Medtech Insight

Finland Cracks Down On Software That Needs Regulating As A Medical Devices

 

Finland has initiated a project to improve the effectiveness of the monitoring of software intended for medical use and to ensure that software placed on its market meets the requirements set for it. 

Milner Pitch Day: Multiomic Pathology, Microcancer Avatars And Cell Morphology Intelligence

 

The Milner Institute, the on-campus hub for start-up acceleration at Cambridge University, hosted its annual Pitch Day on July 1. Start-ups Panakeia, PathwayBio and Sentinal4D presented diagnostic technologies.

Investors Urged To Prioritize Patient Engagement To Ensure Clients’ Products Succeed

 

To succeed in medtech, investors must focus on patient outcomes. Gilde Healthcare says involving patients boosts product effectiveness, access and market success — making it a smart strategy in today’s strained healthcare systems.